As the Ebola outbreak continues in the Democratic Republic of the Congo, experts are contemplating the testing of an unapproved vaccine, given the lack of approved options.
The recent rise in mining petitions in Peru has led to growing concerns about the underlying motivations and entities responsible for these applications.
The Trump administration's new policy may result in patients facing higher out-of-pocket health care costs as skimpier plans are permitted on ACA exchanges.
The 'tradwife' movement claims to empower women by embracing traditional roles. However, a deeper analysis reveals potential connections to far-right ideologies.
Research reveals that the first livestock herders in eastern Africa continued to engage in fishing, hunting, and gathering for up to 1,000 years after introducing cattle into their communities.
The merger between WakeMed and Atrium Health has been under wraps for two years, raising questions about its implications for healthcare delivery.
AstraZeneca has received FDA approval for its hypertension medication, marking a significant development in the biotech sector amid ongoing discussions about FDA leadership and other industry news.
In light of an ongoing Ebola outbreak, the U.S. has enacted a travel ban for individuals from certain affected regions, including the Democratic Republic of the Congo, Uganda, and South Sudan.
The Supreme Court's decision could complicate ongoing lawsuits from pharmaceutical companies regarding drug price negotiations.
Recent data highlights a significant disparity in hospital care costs, showing that private insurance prices have escalated more rapidly than Medicare payments since 2019.
Two advocacy groups are urging the U.K. government to reconsider regulations tied to a U.S. pharma trade deal, threatening legal action if changes are not made.
Several Americans currently in the Congo are thought to have been exposed to suspected Ebola cases amid the ongoing outbreak in the region.
A recent study published in ACS Publications examines the health risks posed by rare earth ions, particularly focusing on their cytotoxic effects and methods for predicting mixed toxicity.
The dead humpback whale, identified as 'Timmy,' highlights ongoing issues regarding marine life conservation in the region after weeks of being stranded.
The recent air strike that resulted in the death of Izz al-Din al-Haddad adds to the tensions surrounding an already fragile ceasefire in the region.
Tracy Beth Høeg's resignation from the FDA's drug center follows the recent departure of Commissioner Marty Makary, highlighting a troubling leadership gap within the agency.
The pharmaceutical industry is witnessing various changes, including new hires and promotions. Ailux has appointed Maria Belvisi as its chief scientific officer.
This editorial explores the federal government's Vaccine Injury Compensation Program and the Countermeasures Injury Compensation Program, highlighting their history and ongoing policy discussions.
The political landscape in the U.K. may influence drug pricing strategies, while the U.S. continues to press Germany for higher drug payments, amidst other health developments.
In the latest Pharmalittle update, the U.S. is applying pressure on Germany regarding drug pricing policies, alongside notable changes within the FDA and developments in biotech clinical trials.